Department of Neurology

January 24, 2023

How arterial “stiffness” may impair cognition

New findings from Vanderbilt neurologists suggest that cardiovascular disease may increase the spaces surrounding blood vessels in the brain and lead to cognitive decline.

By Kelsey Pinckard
January 6, 2023

Early effects of Huntington disease

Impairments in brain executive function happen earlier than motor symptoms in people with the gene mutation that causes Huntington disease, suggesting younger ages and cognitive symptoms be considered for any future clinical trials.

By Kelsey Pinckard
The certification team included, from left, Arlene Boudreaux, MSN, RN, CNRN, Ryan Schell, PharmD, BCPS, Fenna Phibbs, MD, MPH, and Jessica Stroh, RN. (photo by Donn Jones)
December 1, 2022

VUMC receives national certification for Parkinson’s disease care

Vanderbilt University Medical Center recently became the nation’s second health care organization to receive The Joint Commission’s Gold Seal of Approval for Parkinson’s Disease Certification.

By Paul Govern
November 17, 2022

Study examines impulsiveness in Parkinson’s disease

Vanderbilt researchers are studying aspects of dopamine release and its regulation in Parkinson’s patients with and without impulsive-compulsive behaviors.

By Paul Govern
November 10, 2022

Kennedy Center seeks participants for disabilities research learning sessions

In January, a series of online learning sessions hosted by Vanderbilt Kennedy Center will bring together stakeholders who wish to see research advance toward understanding and solving the health problems that tend to affect adults with IDD.

By Paul Govern
November 8, 2022

Alzheimer’s risk factor and cognition

Vanderbilt researchers found that a protein with roles in innate immunity worsens memory at baseline in carriers of APOE-e4, the strongest genetic risk factor for Alzheimer’s disease, further implicating neuroinflammation in cognitive decline.

By Leigh MacMillan
October 18, 2022

VUMC implants first patient in NAUTILUS study for treatment of idiopathic generalized epilepsy

A Vanderbilt patient with idiopathic generalized epilepsy is now the first to receive neuromodular stimulation of the brain to see if it can help with seizures.
By Craig Boerner
October 6, 2022

Gene tied to childhood epilepsy

Data drawn from four unrelated patients with a childhood epilepsy syndrome — and from in vitro and in vivo studies — link novel variants in a GABA transporter gene to seizure activity, Vanderbilt researchers reported.
By Paul Govern
October 6, 2022

VWCH adds epilepsy monitoring unit, onsite neurologist

Vanderbilt Wilson County Hospital has added an epilepsy monitoring unit (EMU), with a neurologist onsite seeing patients in the hospital.
By Craig Boerner
July 11, 2022

A speedier treatment for depression?

Vanderbilt researchers used a computer-based search to identify a compound with promise as a new, mechanistically distinct and rapid-acting therapy for major depressive disorder.
By Paul Govern
May 11, 2022

New Clinician Spotlight: Shailee Shah

Shailee Shah, MD, MS, has joined Vanderbilt University Medical Center as an assistant professor in the Division of Neuroimmunology within the Department of Neurology.
By VUMC News and Communications
May 10, 2022

Autism and sleep problems

Vanderbilt researchers developed a framework for using de-identified medical records to characterize sleep in people on the autism spectrum — a framework that should also be useful for studying other neurodevelopmental disorders.
By Emily Stembridge
April 26, 2022

New Clinician Spotlight: Aaron McMurtray

Specializing in dementia and Alzheimer’s disease, neurologist Aaron McMurtray, MD, PhD, recently joined Vanderbilt University Medical Center as associate professor of Neurology.
By VUMC News and Communications
1 2 3 4 … 9